PSYCH Symposium
@PSYCHSymposium
Followers
14K
Following
3K
Media
829
Statuses
2K
Europe's leading psychedelic medicine conference. Join us on December 4 at Conway Hall, London.
London, England
Joined April 2020
📢 @Drug_Science and Prohibition Partners are excited to announce the return of PSYCH Symposium: London on Dec 4. Tickets on sale now. Stay tuned in the coming months for updates, speaker and panel announcements, and networking opportunities. https://t.co/ovmqiy5PAr
psychsymposium.com
PSYCH Symposium is a one-day psychedelic conference in London on December 4th, exploring psychedelics through leading research, innovation, and insight.
1
1
2
I’m excited to be speaking at @PSYCHSymposium this December, where I’ll be presenting on the future of psychedelic medicine in Europe alongside other leaders in science, policy & investment 🌎 Join me in London🎟️⤵️ https://t.co/XZhxdSWO3n @drugscience
@HeroicHeartsUK
0
2
0
Psychedelics could redefine mental healthcare — but progress depends on collaboration across science, policy, and investment. Don’t just watch change happen — drive it. Join global leaders at #PSYCHSymposium on Dec 4 at Conway Hall, London. https://t.co/ovmqiy5PAr
0
0
0
PSYCH Symposium 2025 speaker Eddie Jacobs (University of Oxford) explains why Europe is shifting from possibility to practice in psychedelic medicine 🌍🍄 The challenge – and opportunity – is building care models that are accountable, trusted & equitable. https://t.co/ovmqiy5PAr
0
0
0
@ProfDavidNutt spoke with us about landmark steps in psych regulation like Australia’s psilocybin/MDMA rescheduling & Germany’s compassionate access policy. Read our Speaker Spotlight for @PSYCHSymposium's upcoming December event.
psychedelichealth.co.uk
Professor David Nutt stands out as a leading figure in modern psychedelic science, tirelessly pushing the boundaries of how drugs such as psilocybin, MDMA, LSD, DMT, and ketamine, are understood,...
0
3
2
✨ PSYCH Symposium returns to London this December as Europe’s landmark event for leaders in psychedelic medicine. 🎥 Learn why past attendees call it the go-to gathering for innovators and investors shaping the future of psychedelic healthcare. https://t.co/OmFsaB7hXo
0
0
0
Super Early Bird tickets to PSYCH Symposium are running low! Don't miss this limited-time deal! @Drug_Science
https://t.co/usOLdbew0K
0
0
0
This week, @rcpsych released a major review of psychedelic-assisted therapies. Their verdict? Big questions remain around durability, safety, and real-world impact. We’re addressing these questions head on at #PSYCHSymposium — 4/12. 👉 Join us:
psychsymposium.com
PSYCH Symposium is a one-day psychedelic conference in London on December 4th, exploring psychedelics through leading research, innovation, and insight.
0
1
0
Less than two weeks until Borealis Psychedelic Science Summit 2025 in Stockholm! Leading voices in psychedelic science & therapy gather, don’t miss out. Partner 15% discount code: PSYCH15 📷 https://t.co/DxlL9JWBoR
0
1
1
"This is one of the key events that take place ... It's an intimate but valuable group of people that meet here." 2023 attendees explain why #PSYCHSymposium is one of the most important events for anyone interested in psychedelic medicine 📹 https://t.co/wByRykqrhY
0
2
1
Matthew Wall, Associate Director of Translational MRI at Perceptive, shares his perspective on the key challenges currently facing the rollout of psychedelic medicines ⬇️ Catch him at PSYCH Symposium on December 4. https://t.co/Gb34U1qHm6
0
0
1
World-class research meets global investment. The UK is at the forefront of psychedelic healthcare innovation. 🌍 PSYCH Symposium 2025 | London | Dec 4 https://t.co/ovmqiy6npZ
3
1
1
⏳ Early bird tickets for #PSYCHSymposium are running low! Don’t miss your chance to score discounted tickets to Europe’s landmark psychedelic medicine gathering. 🌍
0
0
0
PSYCH Symposium will convene leaders in science, medicine, policy, & investment to discuss the future of psychedelic medicine. Position your org at the forefront of one of the most dynamic fields in global health 🤝 Sponsorship opportunities are now open. https://t.co/kQpeLtvKbk
0
1
1
The countdown is on ⏳ Join us at #PSYCHSymposium on 4 Dec in London and help lead the growing momentum for psychedelic medicine. https://t.co/ovmqiy5PAr
0
2
1
This December, I’ll be speaking at one of Europe’s most important events on psychedelic science, policy & investment. Join me at #PSYCHSymposium on 4 Dec in London: https://t.co/53VFLyQC2B @Drug_Science @PSYCHSymposium
psychsymposium.com
PSYCH Symposium is a one-day psychedelic conference in London on December 4th, exploring psychedelics through leading research, innovation, and insight.
0
12
33
We’re thrilled to welcome @ProfDavidNutt to the #PSYCHSymposium stage this December. A global leader in neuropsychopharmacology, Prof. Nutt continues to be at the forefront of research and policy on psychedelic medicine. 👉 Join him at Conway Hall: https://t.co/ovmqiy5PAr
0
1
1
Don’t miss the opportunity to connect with the people driving innovation in psychedelic medicine. Join industry leaders at PSYCH Symposium in London on December 4. Secure your ticket today at the early bird rate, before it's too late: https://t.co/Ttb77ODQaU
0
1
2
🇬🇧 Landmark UK trial to investigate psilocybin for opioid addiction relapse 🇺🇸 Lykos Therapeutics and FDA agree on path forward for MDMA 🧠 Psychedelics show promise in the treatment of OCD Read more in Issue 191 of The Psychedelics Newsletter: https://t.co/X5KENHcX0K
1
3
5
For the first time, a government-funded UK trial will investigate psilocybin-assisted psychotherapy for targetting relapses associated with opioid addiction, aiming to bring an innovative new therapy to the NHS if successful. #Addiction #OpioidAddiction
https://t.co/SRJTF7yVas
psychedelichealth.co.uk
For the first time, a government-funded UK trial will investigate psilocybin-assisted psychotherapy for targetting relapses associated with opioid addiction, aiming to bring an innovative new therapy...
1
5
10